Lymph Node Pathologic Grading Strategy

Fudan University2,998 enrolled

Overview

The percentage of high-grade patterns in metastatic LNs (mLNs) that can predict poor outcomes has yet to be determined. Additionally, the potential implications of other histologic patterns in metastatic lymph nodes on patient outcomes warrant further investigation. We conducted a retrospective cohort study to investigate the prognostic value of pathologic pattern in metastatic lymph nodes.

Study Type

OBSERVATIONAL

Enrollment

2,998

Conditions

Lung Adenocarcinoma

Interventions

No interventionOTHER

No intervention

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: From January 2011 to September 2021, we consecutively collected patients with invasive LUAD who underwent surgical resection at the Department of Thoracic Surgery, Fudan University Shanghai Cancer Center. Exclusion Criteria: 1. adenocarcinoma in situ, minimally invasive adenocarcinoma, invasive mucinous adenocarcinoma, and other variants of adenocarcinoma; 2. incomplete common driver mutation data; 3. unavailable pathologic slides.

Locations (1)

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

RECRUITING

Outcomes

Primary Outcomes

5-year RFS

Time frame: 5 years

Secondary Outcomes

5-year OS

Time frame: 5 years

Central Contacts

Zhu

CONTACT

13301970795 20301050177@fudan.edu.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.